Impella device: Revision history

16 September 2018

• curprev 05:1605:16, 16 September 2018‎ Tarek Nafee talk contribs‎ 32,258 bytes +341‎ No edit summary

25 September 2017

• curprev 13:0113:01, 25 September 2017‎ Tarek Nafee talk contribs‎ 31,917 bytes +568‎ →‎Biventricular Heart Failure

24 September 2017

• curprev 19:1619:16, 24 September 2017‎ Tarek Nafee talk contribs‎ 31,349 bytes +11‎ →‎Clinical Trials
• curprev 19:1219:12, 24 September 2017‎ Tarek Nafee talk contribs‎ 31,338 bytes −36‎ →‎Advantages vs. Disadvantages
• curprev 19:1219:12, 24 September 2017‎ Tarek Nafee talk contribs‎ 31,374 bytes +2,503‎ →‎Alternative Devices
• curprev 18:5618:56, 24 September 2017‎ Tarek Nafee talk contribs‎ 28,871 bytes +1‎ →‎Left Ventricular Heart Failure
• curprev 18:5518:55, 24 September 2017‎ Tarek Nafee talk contribs‎ 28,870 bytes 0‎ →‎Left Ventricular Heart Failure
• curprev 18:4718:47, 24 September 2017‎ Tarek Nafee talk contribs‎ 28,870 bytes +4‎ →‎Left Ventricular Heart Failure
• curprev 18:4718:47, 24 September 2017‎ Tarek Nafee talk contribs‎ 28,866 bytes +4,124‎ →‎Left Ventricular Heart Failure
• curprev 18:1618:16, 24 September 2017‎ Tarek Nafee talk contribs‎ 24,742 bytes +1,791‎ →‎Clinical Practice Guidelines
• curprev 18:1218:12, 24 September 2017‎ Tarek Nafee talk contribs‎ 22,951 bytes +549‎ →‎Cardiogenic Shock
• curprev 18:1118:11, 24 September 2017‎ Tarek Nafee talk contribs‎ 22,402 bytes +477‎ →‎Bridging to Transplantation or Durable Device Placement
• curprev 18:0518:05, 24 September 2017‎ Tarek Nafee talk contribs‎ 21,925 bytes +1,509‎ →‎Cardiogenic Shock
• curprev 18:0118:01, 24 September 2017‎ Tarek Nafee talk contribs‎ 20,416 bytes +2,631‎ →‎High Risk PCI Patients

22 September 2017

• curprev 23:4523:45, 22 September 2017‎ Tarek Nafee talk contribs‎ 17,785 bytes +1,203‎ →‎Indications
• curprev 23:3923:39, 22 September 2017‎ Tarek Nafee talk contribs‎ 16,582 bytes +620‎ →‎Clinical Trials
• curprev 23:3823:38, 22 September 2017‎ Tarek Nafee talk contribs‎ 15,962 bytes −3‎ →‎PROTECT II Trial
• curprev 23:3123:31, 22 September 2017‎ Tarek Nafee talk contribs‎ 15,965 bytes +562‎ →‎Clinical Practice Guidelines Tag: Visual edit
• curprev 23:0023:00, 22 September 2017‎ Tarek Nafee talk contribs‎ 15,403 bytes 0‎ →‎Alternative Options
• curprev 21:5221:52, 22 September 2017‎ Tarek Nafee talk contribs‎ 15,403 bytes +61‎ →‎Structure and Function
• curprev 21:4921:49, 22 September 2017‎ Tarek Nafee talk contribs‎ 15,342 bytes +492‎ →‎Structure and Function
• curprev 21:0121:01, 22 September 2017‎ Tarek Nafee talk contribs‎ 14,850 bytes +732‎ →‎Clinical Practice Guidelines Tag: Visual edit
• curprev 19:4319:43, 22 September 2017‎ Tarek Nafee talk contribs‎ 14,118 bytes +2,135‎ →‎Clinical Practice Guidelines Tag: Visual edit
• curprev 19:2519:25, 22 September 2017‎ Tarek Nafee talk contribs‎ 11,983 bytes +579‎ →‎Overview
• curprev 19:2519:25, 22 September 2017‎ Tarek Nafee talk contribs‎ 11,404 bytes +311‎ →‎Clinical Practice Guidelines Tag: Visual edit
• curprev 19:1219:12, 22 September 2017‎ Tarek Nafee talk contribs‎ 11,093 bytes +63‎ →‎Indications
• curprev 18:1318:13, 22 September 2017‎ Tarek Nafee talk contribs‎ 11,030 bytes +200‎ →‎Alternative Options Tag: Visual edit
• curprev 18:0718:07, 22 September 2017‎ Tarek Nafee talk contribs‎ 10,830 bytes −19‎ →‎Overview Tag: Visual edit
• curprev 18:0618:06, 22 September 2017‎ Tarek Nafee talk contribs‎ 10,849 bytes +97‎ No edit summary Tag: Visual edit
• curprev 18:0218:02, 22 September 2017‎ Tarek Nafee talk contribs‎ 10,752 bytes +395‎ →‎Overview
• curprev 17:4017:40, 22 September 2017‎ Tarek Nafee talk contribs‎ 10,357 bytes +30‎ No edit summary
• curprev 17:3917:39, 22 September 2017‎ Tarek Nafee talk contribs‎ 10,327 bytes +7,680‎ No edit summary

9 August 2012

• curprev 16:2016:20, 9 August 2012‎ WikiBot talk contribs‎ m 2,647 bytes −6‎ Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)

8 December 2010

• curprev 00:5100:51, 8 December 2010‎ C Michael Gibson talk contribs‎ 2,653 bytes +2,653‎ New page: {{CMG}} {{EH}} ==PROTECT II Trial== The trial was discontinued early due to futility. A press release from the manufacturer Abiomed stated the following: "Abiomed announced completion ...